CAR-T Long Term Follow Up (LTFU) Study is a 15-year research project to ensure the safety and efficiency of CAR-T therapy. CAR-T therapy uses modified cells to fight diseases, and this study monitors patients who have received such treatments to check for any long-term side effects and benefits. It also looks for any potential risks, like replication competent lentivirus (RCL), which means the virus used in the therapy could start reproducing on its own. Patients who have completed or left their original CAR-T treatment can join this study to help gather important data. There are no specific exclusion criteria, meaning anyone who received CAR-T therapy in a related study can join. Participants must agree to join the study by providing informed consent, which means they understand the study and agree to be part of it.
- Length of Study: 15 years of follow-up.
- Eligibility: Anyone who has received CAR-T therapy in certain studies.
- No specific risks: No specific exclusion criteria, meaning wide eligibility.